Subbaya Subramanian

University of Minnesota — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

56h-index10.7kcitations291works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

MicroRNA in disease regulation(71), Cancer-related molecular mechanisms research(56), Sarcoma Diagnosis and Treatment(41), Circular RNAs in diseases(37), Cancer Immunotherapy and Biomarkers(35)

Publications291 total

CNSC-44. EVOLUTION OF NEURON-GLIOMA CIRCUIT DYNAMICS THROUGH EPH-A MEDIATED AXONOGENESIS
Neuro-Oncology·2025Open Access
SMAD4 mutation drives gut microbiome shifts toward tumor progression in colorectal cancer
Discover Oncology·2025Open Access
S6239 Unmasking the Silent Culprit: Olmesartan-Induced Gastroenteropathy
The American Journal of Gastroenterology·2025
Data from A Novel Conditionally Replicative Oncolytic Adenovirus under the Control of the <i>SALL4</i> Promoter Inhibits the Growth of Rhabdoid Tumors
2025Open Access
Figure S4 from A Novel Conditionally Replicative Oncolytic Adenovirus under the Control of the <i>SALL4</i> Promoter Inhibits the Growth of Rhabdoid Tumors
2025Open Access
Table S1 from A Novel Conditionally Replicative Oncolytic Adenovirus under the Control of the <i>SALL4</i> Promoter Inhibits the Growth of Rhabdoid Tumors
2025Open Access
Figure S1 from A Novel Conditionally Replicative Oncolytic Adenovirus under the Control of the <i>SALL4</i> Promoter Inhibits the Growth of Rhabdoid Tumors
2025Open Access
Figure S3 from A Novel Conditionally Replicative Oncolytic Adenovirus under the Control of the <i>SALL4</i> Promoter Inhibits the Growth of Rhabdoid Tumors
2025Open Access
Figure S2 from A Novel Conditionally Replicative Oncolytic Adenovirus under the Control of the <i>SALL4</i> Promoter Inhibits the Growth of Rhabdoid Tumors
2025Open Access
Impeding Quorum Sensing Among the Intestinal Microbiota Impacts the Metastatic Rate of Colorectal Cancer
Cancer Medicine·2025Open Access
A Novel Conditionally Replicative Oncolytic Adenovirus under the Control of the <i>SALL4</i> Promoter Inhibits the Growth of Rhabdoid Tumors
Molecular Cancer Therapeutics·2025
Immune Checkpoint Blockade Therapies for Colorectal Cancer: Current Strategies and Emerging Approaches
JCO oncology advances.·2025· 5 citedOpen Access
STEM-CELL DERIVED EXOSOMES IMPROVE MITOCHONDRIAL BIOENERGETICS TO RESTORE CARDIOMYOCYTE FUNCTION IN CHRONICALLY ISCHEMIC MYOCARDIUM
Journal of the American College of Cardiology·2025Open Access
Biomarker potential of allele-specific extracellular vesicles in Gaucher disease
Molecular Genetics and Metabolism·2025
Protocol for applying Tumor Treating Fields in mouse models of cancer using the inovivo system
STAR Protocols·2025· 2 citedOpen Access
SMAD4 Mutation Drives Gut Microbiome Shifts Toward Tumor Progression in Colorectal Cancer
2024· 1 citedOpen Access
The Emerging Role of the Microbiome in Carcinogenesis
Elsevier eBooks·2024
725 QUORUM QUENCHING DECREASES METASTATIC RATE WITHOUT AFFECTING GUT MICROBIOME COMPOSITION IN A COLORECTAL CANCER MODEL
Gastroenterology·2024Open Access
Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers
Molecular Therapy Oncology·2024· 2 citedOpen Access
Centrosomal Protein 55 (CEP55) Drives Immune Exclusion and Resistance to Immune Checkpoint Inhibitors in Colorectal Cancer
Vaccines·2024· 12 citedOpen Access
page 1 of 15Next →

Frequent Co-authors

Matt van de Rijn(15), Clifford J. Steer(14), Torsten O. Nielsen(12), Venugopal Thayanithy(12), Aaron L. Sarver(11), Robert B. West(10), Kelli Montgomery(9), Shirley Zhu(9), Christopher L. Corless(8), Brian P. Rubin(8), John R. Goldblum(7), Michael C. Heinrich(5), Lihua Li(5), Emil Lou(5), Jaime F. Modiano(5), Rajiv M. Patel(4), Íñigo Espinosa(4), Ann L. Oberg(4), Julie M. Cunningham(4), Stephen N. Thibodeau(4)